j.s.r. genetics limited
j.s.r. genetics limited Company Information
Company Number
03902341
Next Accounts
Mar 2026
Shareholders
jsr farms ltd
Group Structure
View All
Industry
Raising of swine/pigs
Registered Address
crane court hesslewood office pa, ferriby road, hessle, HU13 0PA
Website
www.jsrgenetics.comj.s.r. genetics limited Estimated Valuation
Pomanda estimates the enterprise value of J.S.R. GENETICS LIMITED at £8m based on a Turnover of £11.7m and 0.68x industry multiple (adjusted for size and gross margin).
j.s.r. genetics limited Estimated Valuation
Pomanda estimates the enterprise value of J.S.R. GENETICS LIMITED at £8.7m based on an EBITDA of £1.5m and a 5.74x industry multiple (adjusted for size and gross margin).
j.s.r. genetics limited Estimated Valuation
Pomanda estimates the enterprise value of J.S.R. GENETICS LIMITED at £8.9m based on Net Assets of £5.3m and 1.67x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
J.s.r. Genetics Limited Overview
J.s.r. Genetics Limited is a live company located in hessle, HU13 0PA with a Companies House number of 03902341. It operates in the raising of swine/pigs sector, SIC Code 01460. Founded in January 2000, it's largest shareholder is jsr farms ltd with a 100% stake. J.s.r. Genetics Limited is a mature, mid sized company, Pomanda has estimated its turnover at £11.7m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
J.s.r. Genetics Limited Health Check
Pomanda's financial health check has awarded J.S.R. Genetics Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of £11.7m, make it smaller than the average company (£22.7m)
£11.7m - J.s.r. Genetics Limited
£22.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (11.8%)
2% - J.s.r. Genetics Limited
11.8% - Industry AVG
Production
with a gross margin of 23.4%, this company has a comparable cost of product (23.5%)
23.4% - J.s.r. Genetics Limited
23.5% - Industry AVG
Profitability
an operating margin of 11.8% make it more profitable than the average company (9.5%)
11.8% - J.s.r. Genetics Limited
9.5% - Industry AVG
Employees
with 20 employees, this is below the industry average (37)
20 - J.s.r. Genetics Limited
37 - Industry AVG
Pay Structure
on an average salary of £51.1k, the company has a higher pay structure (£39.7k)
£51.1k - J.s.r. Genetics Limited
£39.7k - Industry AVG
Efficiency
resulting in sales per employee of £586.3k, this is equally as efficient (£598.1k)
£586.3k - J.s.r. Genetics Limited
£598.1k - Industry AVG
Debtor Days
it gets paid by customers after 29 days, this is later than average (15 days)
29 days - J.s.r. Genetics Limited
15 days - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is quicker than average (33 days)
17 days - J.s.r. Genetics Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 25 days, this is less than average (94 days)
25 days - J.s.r. Genetics Limited
94 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 152 weeks, this is more cash available to meet short term requirements (8 weeks)
152 weeks - J.s.r. Genetics Limited
8 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 18.1%, this is a lower level of debt than the average (50.4%)
18.1% - J.s.r. Genetics Limited
50.4% - Industry AVG
J.S.R. GENETICS LIMITED financials
J.S.R. Genetics Limited's latest turnover from June 2024 is £11.7 million and the company has net assets of £5.3 million. According to their latest financial statements, J.S.R. Genetics Limited has 20 employees and maintains cash reserves of £3.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 11,726,000 | 10,687,000 | 9,215,000 | 10,916,000 | 11,647,000 | 9,752,000 | 10,375,000 | 9,653,000 | 6,988,000 | 8,785,000 | 9,625,000 | ||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 8,987,000 | 8,084,000 | 7,276,000 | 8,540,000 | 8,994,000 | 7,596,000 | 7,673,000 | 7,010,000 | 4,868,000 | 5,902,000 | 6,938,000 | ||||
| Gross Profit | 2,739,000 | 2,603,000 | 1,939,000 | 2,376,000 | 2,653,000 | 2,156,000 | 2,702,000 | 2,643,000 | 2,120,000 | 2,883,000 | 2,687,000 | ||||
| Admin Expenses | 1,356,000 | 1,578,000 | 1,660,000 | 1,787,000 | 1,989,000 | 2,061,000 | 1,717,000 | 1,692,000 | 1,689,000 | 2,473,000 | 2,823,000 | ||||
| Operating Profit | 1,383,000 | 1,025,000 | 279,000 | 589,000 | 664,000 | 95,000 | 985,000 | 951,000 | 431,000 | 410,000 | -136,000 | ||||
| Interest Payable | 23,000 | 44,000 | 54,000 | 36,000 | 72,000 | 64,000 | 80,000 | 114,000 | 106,000 | 29,000 | |||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | 1,360,000 | 981,000 | 225,000 | 553,000 | 592,000 | 31,000 | 883,000 | 880,000 | 359,000 | 173,000 | -174,000 | ||||
| Tax | -11,000 | -251,000 | 1,000 | -86,000 | 386,000 | 83,000 | 60,000 | -86,000 | -106,000 | 382,000 | |||||
| Profit After Tax | 1,349,000 | 730,000 | 226,000 | 467,000 | 978,000 | 114,000 | 943,000 | 794,000 | 253,000 | 555,000 | -174,000 | ||||
| Dividends Paid | |||||||||||||||
| Retained Profit | 1,349,000 | 730,000 | 226,000 | 467,000 | 978,000 | 114,000 | 943,000 | 794,000 | 253,000 | 555,000 | -174,000 | ||||
| Employee Costs | 1,022,000 | 872,000 | 973,000 | 941,000 | 971,000 | 1,008,000 | 1,029,000 | 1,200,000 | 997,000 | 1,475,000 | 1,206,000 | ||||
| Number Of Employees | 20 | 21 | 24 | 25 | 35 | 29 | 31 | 33 | 33 | 39 | |||||
| EBITDA* | 1,508,000 | 1,146,000 | 405,000 | 738,000 | 842,000 | 279,000 | 1,179,000 | 1,083,000 | 544,000 | 491,000 | -50,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,074,000 | 1,100,000 | 1,195,000 | 1,291,000 | 1,362,000 | 1,505,000 | 1,588,000 | 1,673,000 | 261,000 | 193,000 | 164,000 | 207,000 | 205,269 | 149,670 | 143,000 |
| Intangible Assets | 4,000 | 6,000 | 11,000 | 16,000 | 24,000 | 33,000 | 40,000 | 57,000 | 76,000 | 94,000 | 107,000 | 107,000 | 97,330 | 92,928 | 81,000 |
| Investments & Other | 236,000 | 258,000 | 215,000 | 181,000 | 406,000 | 58 | 58 | 25,000 | |||||||
| Debtors (Due After 1 year) | 27,000 | 80,000 | 452,000 | 718,000 | 639,000 | 205,000 | 154,000 | 124,000 | 210,000 | 376,000 | 406,000 | 406,418 | 1,137,280 | 549,000 | |
| Total Fixed Assets | 1,105,000 | 1,186,000 | 1,658,000 | 2,025,000 | 2,025,000 | 1,743,000 | 2,018,000 | 2,112,000 | 762,000 | 844,000 | 677,000 | 720,000 | 709,075 | 1,379,936 | 798,000 |
| Stock & work in progress | 632,000 | 544,000 | 445,000 | 425,000 | 376,000 | 1,067,000 | 521,000 | 557,000 | 453,000 | 281,000 | 491,000 | 185,000 | 324,632 | 570,773 | 200,000 |
| Trade Debtors | 963,000 | 1,281,000 | 1,322,000 | 1,277,000 | 1,326,000 | 1,211,000 | 1,040,000 | 1,186,000 | 1,107,000 | 1,138,000 | 1,148,000 | 1,431,000 | 1,960,057 | 1,402,660 | 1,586,000 |
| Group Debtors | 1,709,000 | 422,000 | 288,000 | 538,000 | 1,118,000 | 1,500,000 | 1,010,000 | ||||||||
| Misc Debtors | 236,000 | 260,000 | 186,000 | 257,000 | 347,000 | 324,000 | 197,000 | 256,000 | 283,000 | 156,000 | 228,000 | ||||
| Cash | 3,319,000 | 1,865,000 | 2,213,000 | 2,723,000 | 110,000 | 289,000 | 608,000 | 1,000 | 9,000 | 50,000 | 20,000 | 3,939 | 161,976 | 53,000 | |
| misc current assets | 239,000 | ||||||||||||||
| total current assets | 5,389,000 | 3,950,000 | 4,166,000 | 4,682,000 | 3,868,000 | 3,313,000 | 2,654,000 | 2,537,000 | 2,962,000 | 3,084,000 | 2,927,000 | 1,636,000 | 2,288,628 | 2,135,409 | 1,839,000 |
| total assets | 6,494,000 | 5,136,000 | 5,824,000 | 6,707,000 | 5,893,000 | 5,056,000 | 4,672,000 | 4,649,000 | 3,724,000 | 3,928,000 | 3,604,000 | 2,356,000 | 2,997,703 | 3,515,345 | 2,637,000 |
| Bank overdraft | 1,215,000 | 2,057,000 | 2,054,000 | ||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 440,000 | 398,000 | 467,000 | 507,000 | 449,000 | 617,000 | 393,000 | 452,000 | 772,000 | 1,182,000 | 3,473,000 | 1,919,000 | 1,903,143 | 2,339,779 | 1,850,000 |
| Group/Directors Accounts | 366,000 | 425,000 | 1,431,000 | 1,446,000 | 1,766,000 | 1,766,000 | 1,766,000 | ||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 325,000 | 302,000 | 371,000 | 996,000 | 380,000 | 273,000 | 198,000 | 246,000 | 175,000 | 165,000 | |||||
| total current liabilities | 1,131,000 | 1,125,000 | 2,269,000 | 2,949,000 | 2,595,000 | 2,656,000 | 2,357,000 | 1,913,000 | 3,004,000 | 3,401,000 | 3,473,000 | 1,919,000 | 1,903,143 | 2,339,779 | 1,850,000 |
| loans | 1,325,000 | 27,000 | |||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 47,000 | 84,000 | 225,000 | ||||||||||||
| total long term liabilities | 47,000 | 309,000 | 914,000 | 2,150,000 | 2,330,000 | 2,182,000 | 2,000,000 | 3,389,000 | 1,633,000 | 1,032,000 | 84,000 | 225,000 | 306,000 | 367,000 | |
| total liabilities | 1,178,000 | 1,434,000 | 3,183,000 | 5,099,000 | 4,925,000 | 4,838,000 | 4,357,000 | 5,302,000 | 4,637,000 | 4,433,000 | 3,557,000 | 2,144,000 | 2,209,143 | 2,339,779 | 2,217,000 |
| net assets | 5,316,000 | 3,702,000 | 2,641,000 | 1,608,000 | 968,000 | 218,000 | 315,000 | -653,000 | -913,000 | -505,000 | 47,000 | 212,000 | 788,560 | 1,175,566 | 420,000 |
| total shareholders funds | 5,316,000 | 3,702,000 | 2,641,000 | 1,608,000 | 968,000 | 218,000 | 315,000 | -653,000 | -913,000 | -505,000 | 47,000 | 212,000 | 788,560 | 1,175,566 | 420,000 |
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 1,383,000 | 1,025,000 | 279,000 | 589,000 | 664,000 | 95,000 | 985,000 | 951,000 | 431,000 | 410,000 | -136,000 | ||||
| Depreciation | 123,000 | 116,000 | 121,000 | 141,000 | 169,000 | 177,000 | 175,000 | 113,000 | 94,000 | 68,000 | 71,000 | 54,848 | 42 | 37,000 | |
| Amortisation | 2,000 | 5,000 | 5,000 | 8,000 | 9,000 | 7,000 | 19,000 | 19,000 | 19,000 | 13,000 | 15,000 | 10,998 | 15 | ||
| Tax | -11,000 | -251,000 | 1,000 | -86,000 | 386,000 | 83,000 | 60,000 | -86,000 | -106,000 | 382,000 | |||||
| Stock | 88,000 | 99,000 | 20,000 | 49,000 | -691,000 | 546,000 | -36,000 | 104,000 | 172,000 | -210,000 | 306,000 | -139,632 | -246,141 | 370,773 | 200,000 |
| Debtors | -395,000 | -339,000 | -292,000 | -1,769,000 | 1,859,000 | 483,000 | -425,000 | -614,000 | -452,000 | 784,000 | 549,000 | -529,475 | -173,465 | 404,940 | 2,135,000 |
| Creditors | 42,000 | -69,000 | -40,000 | 58,000 | -168,000 | 224,000 | -59,000 | -320,000 | -410,000 | -2,291,000 | 1,554,000 | 15,857 | -436,636 | 489,779 | 1,850,000 |
| Accruals and Deferred Income | 23,000 | -69,000 | -625,000 | 616,000 | 107,000 | 75,000 | -48,000 | 71,000 | 10,000 | 165,000 | |||||
| Deferred Taxes & Provisions | 47,000 | -84,000 | -141,000 | 225,000 | |||||||||||
| Cash flow from operations | 1,916,000 | 997,000 | 13,000 | 3,046,000 | -1,000 | -368,000 | 1,593,000 | 1,258,000 | 318,000 | -1,911,000 | 508,000 | ||||
| Investing Activities | |||||||||||||||
| capital expenditure | -163,000 | -95,000 | |||||||||||||
| Change in Investments | -236,000 | -22,000 | 43,000 | 34,000 | -225,000 | 406,000 | -58 | -24,942 | 25,000 | ||||||
| cash flow from investments | -197,000 | 130,000 | |||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -59,000 | -1,006,000 | -15,000 | -320,000 | 1,766,000 | ||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -1,325,000 | 1,298,000 | 27,000 | ||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -23,000 | -44,000 | -54,000 | -36,000 | -72,000 | -64,000 | -80,000 | -114,000 | -106,000 | -29,000 | |||||
| cash flow from financing | 183,000 | -719,000 | 738,000 | -183,000 | -300,000 | -275,000 | 386,000 | 650,000 | -740,000 | -1,136,000 | 9,000 | ||||
| cash and cash equivalents | |||||||||||||||
| cash | 1,454,000 | -348,000 | -510,000 | 2,613,000 | -179,000 | -319,000 | 608,000 | -1,000 | -8,000 | -41,000 | 30,000 | 16,061 | -158,037 | 108,976 | 53,000 |
| overdraft | -1,215,000 | -842,000 | 3,000 | 2,054,000 | |||||||||||
| change in cash | 1,454,000 | -348,000 | -510,000 | 2,613,000 | -179,000 | -319,000 | 1,823,000 | 841,000 | -11,000 | -2,095,000 | 30,000 | 16,061 | -158,037 | 108,976 | 53,000 |
j.s.r. genetics limited Credit Report and Business Information
J.s.r. Genetics Limited Competitor Analysis
Perform a competitor analysis for j.s.r. genetics limited by selecting its closest rivals, whether from the AGRICULTURE, FORESTRY AND FISHING sector, other mid companies, companies in HU13 area or any other competitors across 12 key performance metrics.
j.s.r. genetics limited Ownership
J.S.R. GENETICS LIMITED group structure
J.S.R. Genetics Limited has 2 subsidiary companies.
Ultimate parent company
1 parent
J.S.R. GENETICS LIMITED
03902341
2 subsidiaries
j.s.r. genetics limited directors
J.S.R. Genetics Limited currently has 5 directors. The longest serving directors include Mr Giles Christie (May 2010) and Mr Richard Buckle (Jan 2025).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Giles Christie | England | 54 years | May 2010 | - | Director |
| Mr Richard Buckle | England | 53 years | Jan 2025 | - | Director |
| Mr Adam Couch | England | 56 years | Jan 2025 | - | Director |
| Mr John Bottomley | United Kingdom | 61 years | Jan 2025 | - | Director |
| Mr James Pontone | England | 47 years | Jan 2025 | - | Director |
P&L
June 2024turnover
11.7m
+10%
operating profit
1.4m
+35%
gross margin
23.4%
-4.1%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
5.3m
+0.44%
total assets
6.5m
+0.26%
cash
3.3m
+0.78%
net assets
Total assets minus all liabilities
Similar Companies
j.s.r. genetics limited company details
company number
03902341
Type
Private limited with Share Capital
industry
01460 - Raising of swine/pigs
incorporation date
January 2000
age
25
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2024
previous names
jsr newsham limited (May 2002)
newsham genetics limited (November 2000)
accountant
-
auditor
RSM UK AUDIT LLP
address
crane court hesslewood office pa, ferriby road, hessle, HU13 0PA
Bank
-
Legal Advisor
-
j.s.r. genetics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to j.s.r. genetics limited. Currently there are 0 open charges and 7 have been satisfied in the past.
j.s.r. genetics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for J.S.R. GENETICS LIMITED. This can take several minutes, an email will notify you when this has completed.
j.s.r. genetics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
